Pharmacogenetic technologies as part of a personalized approach for back pain

DOI: https://doi.org/10.29296/25877305-2021-09-04
Download full text PDF
Issue: 
9
Year: 
2021

S. Mitkovsky(1); N. Ponomareva(1), Candidate of Medical Sciences; V. Mitkovsky(1, 2), Candidate
of Medical Sciences; Professor E. Kiparisova(2), MD; Professor E. Ekusheva(2, 3), MD (1)Central Clinical
Hospital for Rehabilitation Treatment, Federal Biomedical Agency of Russia, Goluboe Village, Moscow Region
(2)Academy of Postgraduate Education, Federal Research and Clinical Center, Federal Biomedical Agency of
Russia, Moscow (3)Belgorod State National Research University

The paper presents an update on the feasibility of a personalized approach and sets forth the criteria for selecting patients with chronic pain for pharmacogenetic testing (PGT). Objective: to improve quality of life in patients with chronic pain through PGT and personalized therapy selection. Genotyping was performed in 22 patients with adverse reactions (ARs) as gastropathies associated with the intake of nonsteroidal anti-inflammatory drugs and hepatotoxicity. The results of CYP2C9*3, CYP2C9*3, and UGT1A1 genotypes were analyzed. According to the results of PGT, the therapy was corrected, causing the ARs to decrease.
Keywords: 
personalized medicine
pharmacogenetic study
biopsychosocial model of illness
multidisciplinary approach
chronic pain

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Walker B.F. The prevalence of low back pain: a systematic review of the literature from 1966 to 1998. J Spinal Disord. 2000; 13 (3): 205–17. DOI: 10.1097/00002517-200006000-00003
  2. Jahno N.N., Kukushkin M.L. Hronicheskaja bol': mediko-biologicheskie i sotsial'no-ekonomicheskie aspekty. Vestnik RAMN. 2012; 9: 54–8 [Yakhno N.N., Kukushkin M.L. Chronic pain: medico-biologic and sotsio-economic aspects. Vestnik Rossiiskoi akademii meditsinskikh nauk = Annals of the Russian Academy of Medical Sciences. 2012; 9: 54–8 (in Russ.)]. DOI: 10.15690/vramn.v67i9.407
  3. Ahmadeeva L.R., Rajanova G.Sh. Ostrye nespetsificheskie boli v pojasnitse kak medikosotsial'naja problema. Sovremennye problemy nauki i obrazovanija. 2016; 3: 113 [Akhmadeeva L.R., Rayanova G.S. Acute non-specific low back pain as a medical and social problem. Modern problems of science and education. 2016; 3: 113 (in Russ.)].
  4. Breivik H., Collett B., Ventafridda V. et al. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain. 2006; 10: 287–333. DOI: 10.1016/j.ejpain.2005.06.009
  5. Epdes Sh.F., Dubinina T.V., Galushko E.A. Boli v nizhnej chasti spiny v obscheklinicheskoj ppaktike. Ter arh. 2008; 5: 59–66 [Érdes S.F., Dubinina T.V., Galushko E.A. Low back pain in general medical practice. Ter arkh. 2008; 80 (5): 59–61 (in Russ.)].
  6. Titova N.V. Patsient s nespetsificheskoj bol'ju v nizhnej chasti spiny: algoritm diagnostiki i terapii. RMZh. 2016; 12: 775–81 [Titova N.V. Patsient s nespetsificheskoi bol’yu v nizhnei chasti spiny: algoritm diagnostiki i terapii. RMZh. 2016; 12: 775–81 (in Russ.)].
  7. Cypress B.K. Characteristics of physician visits for back symptoms: A national perspective. Am J Public Health. 1983; 73 (4): 389–95. DOI: 10.2105/ajph.73.4.389
  8. Jakupov E.Z., Jakupova S.P., Muslimova E.A. Mul'tivektornyj harakter kupirovanija ostroj i hronicheskoj boli i neobhodimost' ispol'zovanija koping-strategij ee preodolenija. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2015; 115 (12): 98–103 [Yakupov É.Z., Yakupova S.P., Muslimova E.A. The multivector nature of relief of acute and chronic pain and necessity of using pain coping strategies. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2015; 115 (12): 98–103 (in Russ)]. DOI: 10.17116/jnevro201511511298-103
  9. Blumer D., Heiborn M. Chronic pain as a variant of depressive disease: the pain prone disorder. J Nerv Dis. 1981; 170: 381–406. DOI: 10.1097/00005053-198207000-00001
  10. Woolf A, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003; 81 (9): 646–56.
  11. Spirin N.N., Kiselev D.V. Problemy hronicheskoj boli v spine: fasetochnyj sindrom. RMZh. 2015; 17: 1025–30 [Spirin N.N., Kiselev D.V. Problemy khronicheskoi boli v spine: fasetochnyi sindrom. RMZh. 2015; 17: 1025–30 (in Russ.)].
  12. Breivik H., Collett B., Ventafridda V. et al. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain. 2006; 10: 287–333. DOI: 10.1016/j.ejpain.2005.06.009
  13. Burchiel K.J. (Ed). Surgical Management of pain. 2nd ed. Thieme, 2015; p. 37–42.
  14. Kotova O.V., Akarachkova E.S., Danilov A.B. Voprosy dlitel'noj terapii bolevyh sindromov. RMZh. 2015; 23 (30): 16–8 [Kotova O.V., Akarachkova E.S., Danilov A.B. Voprosy dlitel’noi terapii bolevykh sindromov. RMZh. 2015; 23 (30): 16–8 (in Russ)].
  15. Zhuravleva M.V., Obzherina A.Ju. Aktual'nye voprosy povyshenija bezopasnosti primenenija nesteroidnyh protivovospalitel'nyh preparatov: znachenie farmakogeneticheskih issledovanij. Vedomosti NTsESMP: Klinicheskaja farmakologija. 2011; 2: 31–4 [Zhuravleva M.V., Obzherina A.Yu. Topical issues of improving the safety of non-steroidal anti-inflammatory drugs: the importance of clinical pharmacology. Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya = The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2011; 2: 31–4 (in Russ.)].
  16. Karateev A.E., Nasonov E.L., Ivashkin V.T. i dr. Klinicheskie rekomendatsii «Ratsional'noe primenenie nesteroidnyh protivovospalitel'nyh preparatov (NPVP) v klinicheskoj praktike», 2015; 41 s. [Karateev A.E., Nasonov E.L., Ivashkin V.T. et al. Klinicheskie rekomendatsii «Ratsional’noe primenenie nesteroidnykh protivovospalitel’nykh preparatov (NPVP) v klinicheskoi praktike», 2015; 41 p. (in Russ.)].
  17. Gel'fand B.R., Protsenko D.N., Babajants A.V. i dr. Ostrye krovotechenija iz verhnih otdelov zheludochno-kishechnogo trakta: ot epidemiologii do formirovanija kontseptsii konservativnoj terapii. Infektsii v hirurgii. 2013; 4: 11–7 [Gelfand B.R., Protsenko D.N., Babayants A.V. et al. Upper gastrointestinal tract acute bleeding: from epidemiology to the conservative therapy concept formation. Infektsii v khirurgii. 2013; 4: 11–7 (in Russ.)].
  18. Harirforoosh S., Asghar W., Jamali F. Adverse Effects of Nonsteroidal Antiinflammatory Drugs: An Update of Gastrointestinal, Cardiovascular and Renal Complications. J Pharm Pharm Sci. 2013; 16 (5): 821–47. DOI: 10.18433/j3vw2f
  19. Stam W., Jansen J., Taylor S. Efficacy of etoricoxib, celecoxib, lumiracoxib, non-selective NSAIDs, and acetaminophen in osteoarthritis: a mixed treatment comparison. Open Rheumatol J. 2012; 6: 6–20. DOI: 10.2174/1874312901206010006
  20. Roelofs P.D., Deyo R.A., Koes B.W. et al. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev. 2008; 1: CD000396. DOI: 10.1002/ 14651858.CD000396.pub3
  21. Maharin O.A., Zhenilo V.M., Patjuchenko O.Ju. Sovremennye predstavlenija o farmakogenetike boli. Anesteziologija i reanimatologija. 2016; 61 (3): 219–23 [Makharin O.A., Zhenilo V.M., Patyuchenko O.Yu. Modern ideas about the pharmacogenetics of pain (review). Russian journal of Anaesthesiology and Reanimatology = Anesteziologiya i Reanimatologiya. 2016; 61 (3): 219–23 (in Russ.)]. DOI: 10.18821/0201-7563-2016-3-219-223
  22. Ignatov Ju.D., Kukes V.G., Mazurov V.I. Klinicheskaja farmakologija nesteroidnyh protivovospalitel'nyh sredstv. M.: GEOTAR-Media, 2010 [Ignatov Yu.D., Kukes V.G., Mazurov V.I. Klinicheskaya farmakologiya nesteroidnykh protivovospalitel’nykh sredstv. M.: GEOTAR-Media, 2010 (in Russ.)].
  23. Sychev D.A., Kukes V.G., Tashenova A.I. Farmakogeneticheskoe testirovanie – novaja meditsinskaja tehnologija. Modernizatsija zdravoohranenija: politika i upravlenie v zdravoohranenii. 2010; 2: 39–43 [Sychev D.A., Kukes V.G., Tashenova A.I. Pharmacogenetic testing: a new medical technology. Modernizatsiya zdravookhraneniya: politika i upravlenie v zdravookhranenii. 2010; 2: 39–43 (in Russ.)].
  24. Blanco G., Martinez C., Ladero J.M. et al. Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding. Pharmacogenet Genomics. 2008; 18 (1): 37–43. DOI: 10.1097/FPC.0b013e3282f305a9
  25. Leonova M.V., Alimova E.E. Farmakogenetika nesteroidnyh protivovospalitel'nyh preparatov: suschestvujuschie problemy dlja klinicheskoj praktiki. Meditsinskij sovet. 2018; 21: 204–9 [Leonova M.V., Alimova E.E. Pharmacogenetics of non-steroidal anti-inflammatory drugs: existing problems for clinical practice. Meditsinskiy sovet = Medical Council. 2018; 21: 204–9 (in Russ.)]. DOI: 10.21518/2079-701X-2018-21-204-209
  26. Muradjan A.A., Blagovestnov D.A., Sychev D.A. Primenenie farmakogeneticheskih podhodov k posleoperatsionnomu obezbolivaniju. Farmakogenetika i farmakogenomika. 2019; 2: 26–17 [Muradyan A.A., Blagovestnov D.A., Sychev D.A. Primenenie farmakogeneticheskikh podkhodov k posleoperatsionnomu obezbolivaniyu. Farmakogenetika i farmakogenomika. 2019; 2: 26–17 (in Russ)]. DOI: 10.24411/2588-0527-2019-10054
  27. Ekusheva E.V. Sovremennye podhody k terapii hronicheskoj ezhednevnoj golovnoj boli. Sibirskoe meditsinskoe obozrenie. 2017; 1: 93–8 [Ekusheva E.V. Current approaches to therapy of chronic daily headache. Siberian Medical Review. 2017; 1: 93–8 (in Russ)]. DOI: 10.20333/2500136-2017-1-93-98